Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 27% ± 9% | |
luminal cell of prostate epithelium | 3 studies | 21% ± 5% |
Insufficient scRNA-seq data for expression of BBC3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 860.43 | 1807 / 1809 | 99% | 20.40 | 467 / 472 |
bladder | 100% | 463.05 | 21 / 21 | 98% | 18.79 | 495 / 504 |
intestine | 100% | 509.02 | 963 / 966 | 98% | 22.59 | 519 / 527 |
stomach | 99% | 375.79 | 356 / 359 | 99% | 21.50 | 283 / 286 |
thymus | 98% | 341.03 | 642 / 653 | 99% | 18.43 | 600 / 605 |
uterus | 98% | 368.26 | 167 / 170 | 99% | 16.17 | 455 / 459 |
kidney | 97% | 359.43 | 86 / 89 | 99% | 14.55 | 890 / 901 |
pancreas | 98% | 432.55 | 320 / 328 | 98% | 17.92 | 174 / 178 |
lung | 100% | 917.08 | 576 / 578 | 95% | 10.70 | 1098 / 1155 |
breast | 98% | 405.69 | 451 / 459 | 94% | 14.50 | 1055 / 1118 |
ovary | 98% | 296.09 | 176 / 180 | 94% | 8.25 | 404 / 430 |
prostate | 100% | 433.02 | 244 / 245 | 91% | 6.43 | 455 / 502 |
liver | 93% | 301.47 | 211 / 226 | 95% | 11.46 | 384 / 406 |
adrenal gland | 93% | 399.20 | 241 / 258 | 92% | 10.13 | 211 / 230 |
esophagus | 89% | 366.71 | 1287 / 1445 | 96% | 11.58 | 175 / 183 |
brain | 88% | 357.16 | 2315 / 2642 | 97% | 7.65 | 682 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 36.01 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.13 | 29 / 29 |
spleen | 100% | 674.20 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.11 | 1 / 1 |
peripheral blood | 99% | 1124.57 | 924 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 367.11 | 1309 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.94 | 44 / 45 |
adipose | 96% | 288.00 | 1151 / 1204 | 0% | 0 | 0 / 0 |
muscle | 92% | 577.42 | 737 / 803 | 0% | 0 | 0 / 0 |
heart | 89% | 196.00 | 767 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090200 | Biological process | positive regulation of release of cytochrome c from mitochondria |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0070245 | Biological process | positive regulation of thymocyte apoptotic process |
GO_1903896 | Biological process | positive regulation of IRE1-mediated unfolded protein response |
GO_0006974 | Biological process | DNA damage response |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0070231 | Biological process | T cell apoptotic process |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_2000271 | Biological process | positive regulation of fibroblast apoptotic process |
GO_1902237 | Biological process | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_2001056 | Biological process | positive regulation of cysteine-type endopeptidase activity |
GO_0001836 | Biological process | release of cytochrome c from mitochondria |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_0006915 | Biological process | apoptotic process |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0044346 | Biological process | fibroblast apoptotic process |
GO_0045926 | Biological process | negative regulation of growth |
GO_1903749 | Biological process | positive regulation of establishment of protein localization to mitochondrion |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005739 | Cellular component | mitochondrion |
GO_0005764 | Cellular component | lysosome |
GO_0005829 | Cellular component | cytosol |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0051117 | Molecular function | ATPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BBC3 |
Protein name | Bcl-2-binding component 3, isoforms 3/4 (JFY-1) (p53 up-regulated modulator of apoptosis) Bcl-2-binding component 3, isoforms 1/2 (JFY-1) (p53 up-regulated modulator of apoptosis) |
Synonyms | PUMA |
Description | FUNCTION: [Isoform 3]: Does not affect cell growth. . FUNCTION: Essential mediator of p53/TP53-dependent and p53/TP53-independent apoptosis . Promotes partial unfolding of BCL2L1 and dissociation of BCL2L1 from p53/TP53, releasing the bound p53/TP53 to induce apoptosis . Regulates ER stress-induced neuronal apoptosis (By similarity). . |
Accessions | Q96PG8 ENST00000439096.3 [Q9BXH1-1] ENST00000341983.8 [Q9BXH1-2] Q9BXH1 ENST00000449228.5 [Q96PG8-2] ENST00000300880.11 [Q96PG8-1] |